We are live on !
Find out more
Bartlett & Co Portfolio holdings
AUM
$6.16B
Turnover
12.86%
1-Year Est. Return
20.29%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+20.29%
3 Year Est. Return
+30.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
+$590M
(+11%)
Cap. Flow
+$26M
Cap. Flow % of AUM
Cap. Flow %
0.42%
Top 10 Holdings %
Top 10 Hldgs %
30.5%
Holding
1,314
New
118
Increased
226
Reduced
290
Closed
51
Avg Time Held
3.3
years
Top 10 Avg Time Held
4.2
years
Top 20 Avg Time Held
5.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$26.9M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$11.7M |
| 3 |
Procter & Gamble
PG
|
+$11M |
| 4 |
McCormick & Company Non-Voting
MKC
|
+$10M |
| 5 |
JPMorgan US Quality Factor ETF
JQUA
|
+$9.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enbridge
ENB
|
+$47.6M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$12.7M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$7.97M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$5.21M |
| 5 |
NextEra Energy
NEE
|
+$4.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.28% |
| 2 | Miscellaneous | 17.67% |
| 3 | Healthcare | 12.33% |
| 4 | Financials | 11.49% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5T
| $370M | 6.01% |
1,913,556
-9,866
| -0.5% | -$1.82M |
2013 Q2
42 quarters
|
|
2
Microsoft
MSFT
$3.96T
| $369M | 5.99% |
982,883
-2,256
| -0.2% | -$803K |
2013 Q2
42 quarters
|
|
3
Alphabet (Google) Class C
GOOG
$4.16T
| $203M | 3.3% |
1,438,390
+13,925
| +1% | +$1.89M |
2013 Q2
42 quarters
|
|
4
Berkshire Hathaway Class B
BRK.B
$1.14T
| $149M | 2.42% |
416,781
+1,744
| +0.4% | +$612K |
2013 Q2
42 quarters
|
|
5
Mastercard
MA
$540B
| $144M | 2.34% |
337,961
-2,060
| -0.6% | -$828K |
2013 Q2
42 quarters
|
|
6
JPMorgan Chase
JPM
$886B
| $140M | 2.27% |
821,117
+2,427
| +0.3% | +$368K |
2013 Q2
42 quarters
|
|
|
7
Procter & Gamble
PG
$366B
| $140M | 2.27% |
957,745
+74,340
| +8% | +$11M |
2013 Q2
42 quarters
|
|
8
Lowe's Companies
LOW
$110B
| $129M | 2.09% |
577,975
-6,509
| -1% | -$1.32M |
2013 Q2
42 quarters
|
|
9
Abbott
ABT
$180B
| $121M | 1.96% |
1,094,444
+7,231
| +0.7% | +$722K |
2013 Q2
42 quarters
|
|
10
Amazon
AMZN
$2.83T
| $114M | 1.85% |
743,243
+20,571
| +3% | +$2.88M |
2015 Q4
32 quarters
|
|
11
Costco
COST
$441B
| $112M | 1.82% |
165,627
-2,810
| -2% | -$1.67M |
2013 Q2
42 quarters
|
|
12
PepsiCo
PEP
$182B
| $112M | 1.82% |
656,526
+10,444
| +2% | +$1.73M |
2013 Q2
42 quarters
|
|
13
TJX Companies
TJX
$162B
| $111M | 1.8% |
1,189,027
+25,696
| +2% | +$2.31M |
2013 Q2
42 quarters
|
|
14
Amgen
AMGN
$230B
| $111M | 1.79% |
383,241
+1,551
| +0.4% | +$423K |
2013 Q2
42 quarters
|
|
15
Vanguard S&P 500 ETF
VOO
$1.04T
| $106M | 1.72% |
241,841
+5,357
| +2% | +$2.19M |
2015 Q2
34 quarters
|
|
16
Accenture
ACN
$145B
| $97.6M | 1.58% |
277,465
-788
| -0.3% | -$254K |
2013 Q2
42 quarters
|
|
17
Thermo Fisher Scientific
TMO
$251B
| $92.7M | 1.51% |
173,885
+3,541
| +2% | +$1.71M |
2013 Q2
42 quarters
|
|
18
Linde
LIN
$232B
| $91.1M | 1.48% |
222,400
+180
| +0.1% | +$71K |
2018 Q4
20 quarters
|
|
19
UnitedHealth
UNH
$365B
| $86.7M | 1.41% |
165,132
+779
| +0.5% | +$415K |
2013 Q2
42 quarters
|
|
20
Deere & Co
DE
$169B
| $82.9M | 1.35% |
206,751
+959
| +0.5% | +$362K |
2013 Q2
42 quarters
|
|
21
Analog Devices
ADI
$191B
| $78.1M | 1.27% |
390,064
+2,847
| +0.7% | +$508K |
2016 Q3
29 quarters
|
|
22
iShares Core MSCI EAFE ETF
IEFA
$189B
| $77.7M | 1.26% |
1,104,545
+31,089
| +3% | +$2.05M |
2015 Q4
32 quarters
|
|
23
Intuit
INTU
$87B
| $76.9M | 1.25% |
122,497
+6,050
| +5% | +$3.34M |
2019 Q2
18 quarters
|
|
24
Johnson & Johnson
JNJ
$612B
| $74.1M | 1.2% |
473,519
+7,138
| +2% | +$1.09M |
2013 Q2
42 quarters
|
|
25
Booz Allen Hamilton
BAH
$8.91B
| $70.1M | 1.14% |
551,678
+3,622
| +0.7% | +$452K |
2020 Q4
12 quarters
|
|
Similar funds
Bartlett & Co's Q4 2023 Portfolio in Review
As of Q4 2023, Bartlett & Co held 1,314 positions worth $6.16B, up 11% from $5.57B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Bartlett & Co's Q4 2023 filing shows 118 new, 226 increased, 290 reduced and 51 closed positions. Its largest new stake was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M. The largest sale was Enbridge, an estimated $47.6M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Miscellaneous and Healthcare.
- Bartlett & Co's largest Q4 2023 buy was JPMorgan US Quality Factor ETF: 201,376 shares worth $9.7M.
- Bartlett & Co added most to Chevron in Q4 2023, an estimated $26.9M increase.
- Bartlett & Co's biggest Q4 2023 reduction was Enbridge, cutting an estimated $47.6M.
- Bartlett & Co fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $7.97M.
- Bartlett & Co's ten largest holdings make up 30% of its $6.16B portfolio in Q4 2023.
- Bartlett & Co opened 118 new positions and closed 51 in Q4 2023.
- Bartlett & Co's portfolio value rose 11% quarter-over-quarter to $6.16B.
Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.